Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune.
D003524:Cyclosporins / Q000009:adverse effects*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation; D008223:Lymphoma / Q000209:etiology*; D009369:Neoplasms / Q000209:etiology*; D011358:Product Surveillance, Postmarketing; D012306:Risk
D003524:Cyclosporins